Plain-English translation of NCT07459478 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Vasovagal syncope is a common type of fainting that happens when your heart rate or blood pressure suddenly drops. This trial is testing whether adding a tilt table test to standard care helps people with this condition recover better and have fewer fainting spells. Half of the participants will receive standard care plus a tilt table test, while the other half will receive standard care alone (which includes education, lifestyle advice, and biofeedback training).
Doctors often use tilt table tests to diagnose and treat vasovagal syncope, but there is not yet strong scientific evidence that the test actually improves patient outcomes. This trial aims to find out whether adding the tilt table test to standard care truly makes a real difference in helping people feel better.
You likely qualify if…
You likely don't qualify if…
You will first receive standard care, which includes a medical evaluation, education about your condition, and lifestyle advice with biofeedback training. Then you will be randomly assigned to one of two groups: one group will have a tilt table test (where you lie on a special table that slowly tilts you upright while doctors monitor your heart rate and blood pressure), and the other group will continue with standard care alone. The study will track your symptoms and fainting episodes over time to see which approach works better.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
Netherlands
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment target
~238 participants
Started
October 2025
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Thomas T Boel, MD
AmsterdamUMC
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.